1007257

MedImmune U.K. Limited — FEI 3004066112

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liverpool (United Kingdom)